학술논문
Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM–INSULIN trial
Document Type
Article
Author
Source
In Diabetes and Metabolism October 2017 43(5):453-459
Subject
Language
ISSN
1262-3636